Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Karlsson

Showing results (141-150 of 565) with videos related to

Pageof 57
Sort By:
Journal of Proteome Research|March 26, 2009
Discovery and identification of serine and threonine phosphorylated proteins in activated mast cells: implications for regulation of protein synthesis in the rat basophilic leukemia mast cell line RBL-2H3Fredrik J Olson, Russell I Ludowyke, Niclas G Karlsson
Lakartidningen|September 6, 1989
[Hemorrhage and transfusion in routine surgery increases the risk of delayed healing, infection and mortality]P O Nyström, J Berglund, G Karlsson, et al.
Antioxidants (Basel, Switzerland)|September 3, 2020
Comment on "Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity" <i>Antioxidants</i> 2020, <i>9</i>, 594Jan Eric Stehr, Ingemar Lundström, Jan Olof G Karlsson
Antioxidants (Basel, Switzerland)|December 24, 2021
The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOxJan Olof G Karlsson, Per Jynge, Louis J Ignarro
Antioxidants (Basel, Switzerland)|March 29, 2023
Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn<sup>2+</sup> and Oxaliplatin-Associated Pt<sup>2</sup>Jan Olof G Karlsson, Per Jynge, Louis J Ignarro
International Journal of Oncology|December 9, 2004
Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-IIIngirídur Skírnisdóttir, Tomas Seidal, Mats G Karlsson, et al.
Leukemia Research|May 19, 1998
Differences in CD14 and alpha-naphthyl acetate esterase positivity and relation to prognosis in AMLM Fergedal, M Aström, U Tidefelt, et al.
Biochemistry|May 23, 2000
Side-chain interactions in the plastocyanin-cytochrome f complexM Ejdebäck, A Bergkvist, B G Karlsson, et al.
Oncology Reports|June 18, 2004
Relation between HPV-DNA and expression of p53, bcl-2, p21WAF-1, MIB-1, HER-2/neu and DNA ploidy in early cervical carcinoma: correlation with clinical outcomeM Graflund, B Sorbe, S Sigurdardóttir, et al.
Lakartidningen|June 2, 1971
[The liability of the committe of responsible. The committe of responsible has not increased their judgement]A Björkman, C F Hadding, G Karlsson, et al.
Pageof 57

Showing results (141-150 of 565) with videos related to

Sort By:
Pageof 57
Journal of Proteome Research|March 26, 2009
Discovery and identification of serine and threonine phosphorylated proteins in activated mast cells: implications for regulation of protein synthesis in the rat basophilic leukemia mast cell line RBL-2H3Fredrik J Olson, Russell I Ludowyke, Niclas G Karlsson
Lakartidningen|September 6, 1989
[Hemorrhage and transfusion in routine surgery increases the risk of delayed healing, infection and mortality]P O Nyström, J Berglund, G Karlsson, et al.
Antioxidants (Basel, Switzerland)|September 3, 2020
Comment on "Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity" <i>Antioxidants</i> 2020, <i>9</i>, 594Jan Eric Stehr, Ingemar Lundström, Jan Olof G Karlsson
Antioxidants (Basel, Switzerland)|December 24, 2021
The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOxJan Olof G Karlsson, Per Jynge, Louis J Ignarro
Antioxidants (Basel, Switzerland)|March 29, 2023
Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn<sup>2+</sup> and Oxaliplatin-Associated Pt<sup>2</sup>Jan Olof G Karlsson, Per Jynge, Louis J Ignarro
International Journal of Oncology|December 9, 2004
Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-IIIngirídur Skírnisdóttir, Tomas Seidal, Mats G Karlsson, et al.
Leukemia Research|May 19, 1998
Differences in CD14 and alpha-naphthyl acetate esterase positivity and relation to prognosis in AMLM Fergedal, M Aström, U Tidefelt, et al.
Biochemistry|May 23, 2000
Side-chain interactions in the plastocyanin-cytochrome f complexM Ejdebäck, A Bergkvist, B G Karlsson, et al.
Oncology Reports|June 18, 2004
Relation between HPV-DNA and expression of p53, bcl-2, p21WAF-1, MIB-1, HER-2/neu and DNA ploidy in early cervical carcinoma: correlation with clinical outcomeM Graflund, B Sorbe, S Sigurdardóttir, et al.
Lakartidningen|June 2, 1971
[The liability of the committe of responsible. The committe of responsible has not increased their judgement]A Björkman, C F Hadding, G Karlsson, et al.
Pageof 57